Literature DB >> 30210139

Number of Board-Certified Cardiologists and Acute Myocardial Infarction-Related Mortality in Japan - JROAD and JROAD-DPC Registry Analysis.

Koshiro Kanaoka1,2, Satoshi Okayama1, Kihei Yoneyama3, Michikazu Nakai4, Kunihiro Nishimura4, Hiroyuki Kawata1, Manabu Horii2, Rika Kawakami1, Hiroyuki Okura1, Yoshihiro Miyamoto4, Yoshihiro Akashi3, Yoshihiko Saito1.   

Abstract

BACKGROUND: The appropriate number of board-certified cardiologists (BCC) for the treatment of acute myocardial infarction (AMI) has not been thoroughly examined in Japan. This study investigated whether the number of BCC/50 cardiovascular beds affects acute outcome in AMI treatment. Methods and 
Results: Data on 751 board-certified teaching hospitals and 63,603 patients with AMI were obtained from the Japanese Registry Of All cardiac and vascular Diseases (JROAD) and JROAD Diagnosis Procedure Combination (JROAD-DPC) databases between 1 April 2012 and 31 March 2014. The hospitals were categorized into 3 groups based on the median number of BCC/50 cardiovascular beds: first tertile, 5.0 (IQR, 4.0-5.7); second, 8.3 (IQR, 7.4-9.8); third, 15.3 (IQR, 12.5-22.7), and the patients with AMI admitted to the categorized hospitals were compared (first tertile, 12,002 patients; second, 23,930; third, 27,671). On hierarchical logistic modeling, the adjusted OR for 30-day mortality were 0.86 (95% CI: 0.74-1.00) for the second tertile and 0.75 (95% CI: 0.65-0.88) for the third tertile.
CONCLUSIONS: Patients with AMI admitted to hospitals with a large number of BCC/50 cardiovascular beds had a lower 30-day mortality rate. This tendency was independent of patient and hospital characteristics. This is the first study to provide new information on the association between the number of BCC and in-hospital AMI-related mortality in Japan.

Entities:  

Keywords:  Acute myocardial infarction; Cardiologist; Diagnosis Procedure Combination (DPC); Japanese Registry Of All cardiac and vascular Diseases (JROAD); Mortality

Mesh:

Year:  2018        PMID: 30210139     DOI: 10.1253/circj.CJ-18-0487

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  Resources for cardiovascular healthcare associated with 30-day mortality in acute myocardial infarction with cardiogenic shock.

Authors:  Masanobu Ishii; Kenichi Tsujita; Hiroshi Okamoto; Satoshi Koto; Takeshi Nishi; Michikazu Nakai; Yoko Sumita; Yoshitaka Iwanaga; Nobuyoshi Azuma; Satoaki Matoba; Ken-Ichi Hirata; Yutaka Hikichi; Hiroyoshi Yokoi; Yuji Ikari; Shiro Uemura
Journal:  Eur Heart J Open       Date:  2021-12-31

Review 2.  CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.

Authors:  Yukio Ozaki; Hironori Hara; Yoshinobu Onuma; Yuki Katagiri; Tetsuya Amano; Yoshio Kobayashi; Takashi Muramatsu; Hideki Ishii; Ken Kozuma; Nobuhiro Tanaka; Hitoshi Matsuo; Shiro Uemura; Kazushige Kadota; Yutaka Hikichi; Kenichi Tsujita; Junya Ako; Yoshihisa Nakagawa; Yoshihiro Morino; Ichiro Hamanaka; Nobuo Shiode; Junya Shite; Junko Honye; Tetsuo Matsubara; Kazuya Kawai; Yasumi Igarashi; Atsunori Okamura; Takayuki Ogawa; Yoshisato Shibata; Takafumi Tsuji; Junji Yajima; Kaoru Iwabuchi; Nobuo Komatsu; Teruyasu Sugano; Masaru Yamaki; Shinichiro Yamada; Hiroaki Hirase; Yuusuke Miyashita; Fuminobu Yoshimachi; Masakazu Kobayashi; Jiro Aoki; Hirotaka Oda; Yoshiaki Katahira; Kinzo Ueda; Masami Nishino; Koichi Nakao; Ichiro Michishita; Takafumi Ueno; Taku Inohara; Shun Kohsaka; Tevfik F Ismail; Patrick W Serruys; Masato Nakamura; Hiroyoshi Yokoi; Yuji Ikari
Journal:  Cardiovasc Interv Ther       Date:  2022-01-12

3.  The Effectiveness of Mobile Cloud 12-Lead Electrocardiogram Transmission System in Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Toyonori Arinaga; Yasunori Suematsu; Ayumi Nakamura; Tomoki Imaizumi; Yohsuke Hanaoka; Toshimitsu Takagi; Hidenobu Koga; Hironori Tanaka; Yasuhiko Shokyu; Shin-Ichiro Miura
Journal:  Medicina (Kaunas)       Date:  2022-02-06       Impact factor: 2.430

Review 4.  Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan.

Authors:  Katsutoshi Hiramatsu; Annabel Barrett; Yasuhiko Miyata
Journal:  Drugs Real World Outcomes       Date:  2021-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.